You are now leaving the Otrivin.me site and moving to an external website independently operated and not managed by GSK.

GSK assumes no responsibility for the site.

If you wish to leave the site, click 'continue'.

  • Middle East
    • English
    • Arabic

Font size  A A A

  • Feel better
  • Symptoms
  • Our range
  • FAQs
  • Contact us

Consult your doctor / pharmacist before using the products.
This website is intended for residents of Middle East only (except Saudi Arabia).
Use of this web site is subject to our Terms of Use.
Trademarks are owned by or licensed to the Haleon group of companies.
All rights reserved.
FY63W2HO-141223
PM-BH-OTRI-23-00004
PM-BH-OTRIA-22-00002
PM-BH-OTRI-23-00005

 

Haleon. Registered in England and Wales No. 3888792.

Please refer to PIL leaflet for more information about the product.

  • Privacy Policy
  • Cookie Policy
  • Terms of use
  • Product Leaflets
  • Sitemap
 
  • Privacy Policy
  • Cookie Policy
  • Terms of use
  • Product Leaflets
  • Sitemap
Required
EnlargeReduce Conclude

Always read label before use. If you wish to report any adverse event, product quality complaint, or Medical enquiry, please contact us at mystory.ae@haleon.com or +973 16500 404.
Small print
Consult your doctor / pharmacist before using the products.
This website is intended for residents of Middle East only (except Saudi Arabia).
Use of this web site is subject to our Terms of Use.
Trademarks are owned by or licensed to the Haleon group of companies.
All rights reserved.
FY63W2HO-141223
PM-BH-OTRI-23-00004
PM-BH-OTRIA-22-00002
PM-BH-OTRI-23-00005
Haleon. Registered in England and Wales No. 3888792.
gsk small logo